Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyurea-induced dermatomyositis-like eruption

P Senet1, S Aractingi, M Porneuf

  • 1Service de Dermatologie, Hôpital Gilles de Corbeil, France.

The British Journal of Dermatology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Hydroxyurea can cause rare skin reactions, like dermatomyositis-like lesions on the hands, in patients with myeloproliferative syndromes. This adverse effect is usually benign and often doesn't require stopping treatment.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supramolecular microgels for Pickering emulsion stabilization in the limited coalescence regime: The key role of microgel structure.

Journal of colloid and interface science·2026
Same author

Skull Vibration Induced afternystagmus: A new clinical indicator of superior canal dehiscence.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Management of hypertensive leg ulcers: A French national survey.

Annales de dermatologie et de venereologie·2025
Same author

Nailfold capillaroscopy in acrocyanosis among patients with associated Raynaud's phenomenon.

Annales de dermatologie et de venereologie·2024
Same author

Routine dermatology training and tele-expertise for general practitioners.

Annales de dermatologie et de venereologie·2024
Same author

"SCULP" study: The benefits of skin graft pellets on the pain of sickle cell leg ulcers (SCLU).

Journal de medecine vasculaire·2023
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
Same journal

Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

The British journal of dermatology·2026
Same journal

EPHX3-nEDD: from molecular diagnosis to epidermal lipid biology.

The British journal of dermatology·2026
Same journal

BAP1-tumour predisposition syndrome.

The British journal of dermatology·2026
Same journal

Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

The British journal of dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology
  • Hematology

Background:

  • Hydroxyurea is a common treatment for myeloproliferative syndromes.
  • Cutaneous reactions to hydroxyurea are uncommon.
  • Dermatomyositis-like lesions are a rare reported side effect.